Oral administration. Swallow the tablet whole with water. Can be taken with or without food. Take at the same time each day.

Linlid acts by selectively inhibiting a newly identified enzyme involved in hepatic glucose production and peripheral glucose reuptake, leading to reduced fasting and postprandial glucose levels without stimulating insulin secretion, thereby minimizing hypoglycemia risk.

• •Hypersensitivity to Linlid or any component of the formulation.
• •Patients with type 1 diabetes mellitus.
• •Diabetic ketoacidosis.

Store below 30°C in a dry place, away from direct light and moisture. Keep out of reach of children.

In case of overdose, initiate symptomatic and supportive measures. No specific antidote is known. Hemodialysis is unlikely to be effective due to high protein binding.

Pregnancy Category C. Use only if potential benefit justifies potential risk to the fetus. Not recommended during lactation; consider discontinuing nursing or the drug.